Interventional Cardiology Resource Center Editorial Programs

 
 
  • Interventional Cardiology: Physician and Proceduralist 'I do not want to be known as a high- or a low-volume operator,' writes, Jaya Mallidi, MD, in a plea for her field to value critical thinking as much as it celebrates the latest Impella case.
  • Life and Times of Leading Cardiologists: Holger Thiele   Holger Thiele's career in cardiogenic shock began in West Berlin where he witnessed the fall of the wall and moved to Leipzig to pursue cardiology. This former ironman still bikes to the hospital.
  • Dual vs Triple Antithrombotic Therapy? The Debate Continues   Is a NOAC plus an antiplatelet drug enough to prevent thromboses? Stroke? What doses and combinations are safest? Christian Ruff, Mike Gibson, and Chris Cannon examine the evidence.
  • Mandrola's Top 10 Cardiology Stories of 2018 From blood pressure management in the community to a study on potentially biased referees -- John Mandrola reviews his picks for the year's big stories in cardiology and medicine.
  • AHA 2018Think You're Immune From Bias? Think Again John Mandrola, MD, is intrigued by two studies at AHA that track the cognitive and financial biases that may influence what physicians do in practice and how they write and read research papers.
  • CV Risk: Can Prescription Omega-3 REDUCE-IT?   Low-dose omega-3 flopped for CV risk reduction. Melissa Walton-Shirley, MD, dissects the REDUCE-IT trial from AHA, which used high-dose prescription EPA, with principal investigator, Deepak Bhatt, MD.
  • Mandrola Previews AHA 2018 Among the highlights for the upcoming American Heart Association Scientific Sessions are studies on omega-3, inflammation, a potential EP breakthrough, and yoga. Not to mention new lipid guidelines.
  • Vulnerable Plaque: Are Targeted Therapies Within Reach? Recent studies aim to move vulnerable plaque identification into the cath lab routine. Can these tests pinpoint who will benefit most from aggressive pharmacologic therapies and maybe even stents?
  • Requiem for Aspirin in Dual Antiplatelet Therapy?   Mounting evidence makes Dr Michelle O'Donoghue wonder whether the perennial question on the optimal duration of DAPT should be revised to: How soon can you drop the aspirin? Have you changed your practice?
  • Closing the Office Door for the Last Time With a heavy heart, Melissa Walton-Shirley bids farewell to full-time practice. Ailing parents and RVU demands drive this transition to a new stage in her career.
  • TCT 2018MitraClip for Secondary MR -- The Redux Two conflicting studies on the percutaneous treatment of secondary mitral regurgitation in patients with heart failure lead John Mandrola, MD, to compare and contrast as we await the tiebreaker third.
  • Beta-Blockade After MI: No Practice Should Be Set in Stone Meta-analyses suggest little benefit for beta-blockers in contemporary patients with normal ejection fraction after MI. What other dogma should be revisited in light of an evolving evidence base?
  • Who Is the 'Cardiometabolic Specialist'?   With new diabetes drugs available that lower cardiovascular risk, the question arises over which specialty will manage this area of medicine. Or will a new specialty emerge?
  • ESC 2018Do Cardiologists Care About CV Prevention? Everyone agrees that prevention is better than cure. However, few ESC attendees joined Melissa Walton-Shirley for the session on CVD prevention, preferring to stand in line to hear the latest hotlines.
  • When EHRs (and Doctors) Don't Communicate With Each Other When requests for medical records draw no response, time and money are wasted. Can't we do better in the age of electronic health records, asks Melissa Walton-Shirley.
  • For Better Clinical Research, Collaborate With Statisticians   Volunteering at a VA hospital was the first step in biostatistician Frank Harrell's illustrious career in cardiovascular research.
  • Did Marijuana Save Kevin Smith's Life? After his MI, the self-anointed comic-book man claims he was told that smoking marijuana didn't cause the heart attack and may even have saved his life. Cardiologist Christopher Labos investigates.
  • Tight Blood Glucose Control in Cardiac Surgery Patients Does intensive, perioperative glucose control benefit patients with or without diabetes undergoing cardiac surgery?
  • Cardio Twitter: An Essential Tool for Staying Current   Drs Harrington and Yeh discuss the pros, cons, and cautions of using Twitter in the cardiovascular community.
  • Physiological Analysis of ORBITA Trial Yields New Lessons   Speaking with Dr Rasha Al-Lamee, ORBITA's lead investigator, on the latest data to come out of the controversial trial.
viagra 100mg

viagra-on.com

steroid-pharm.com/